Delivery Order SPE2DR25D3301-SPE2DR26F22CG
Award Date 2/9/26
Potential Completion Date 3/3/26
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Defense Logistics Agency awarded a $4,229.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ZOLADEX 10.8 MG IMPLANT SYRNS. The delivery order was awarded on October 16, 2023 under the corporate vendor's blanket purchase agreement and has a period of performance through November 6, 2023. The delivery order utilizes no set-aside designation and will be fulfilled out of the vendor's location in Conshohocken, Pennsylvania to support the Defense Logistics Agency's medical...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Zoladex 3.6 mg implant syringes, with a ceiling value of $2,155.68 and an ultimate completion date of February 27, 2026.</p> <p>Place of performance is Conshohocken, PA. The order was issued on a firm fixed price basis with no set-aside.</p>
- The Defense Logistics Agency awarded a $4,229.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ZOLADEX 10.8 mg implants. As the prime contractor, Amerisourcebergen will provide the implants to support the Defense Logistics Agency's medical supply needs. Performance will take place in Conshohocken, Pennsylvania over a three week period concluding on August 23, 2023. The delivery order was issued against an existing Amerisourcebergen contract vehicle but no additional...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Zoladex 10.8 mg implant syringes with a ceiling value of $6,055.80 under a firm fixed-price arrangement.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026. No set-aside was used.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for Zoladex 10.8 mg implant syringes, with a ceiling value of $2,018.60 and ultimate completion date of March 2, 2026.</p> <p>The order is issued under Amerisourcebergen's parent Indefinite Delivery Contract with DLA Troop Support Medical, a global pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA.</p>
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of ZOLADEX 3.6 MG Implant Syringes at a firm fixed price of $2,092.74, with an ultimate completion date of November 24, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,648.75 to AmerisourceBergen Drug Corp for ZOLADEX 10.8 MG implant syringes, with performance in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on July 1, 2025, represents completion by July 23, 2025. The contract was competitively awarded with no set-aside designation, demonstrating AmerisourceBergen's capability to meet federal pharmaceutical procurement requirements through open competition. This...
- The Defense Logistics Agency awarded a $3,592.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ZOLADEX 3.6 MG implant syringes, with an ultimate completion date of February 13, 2026. This non-set-aside contract was awarded competitively on January 23, 2026, with performance to be executed from the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,985.82 to AmerisourceBergen Drug Corp for ZOLADEX 3.6 mg implant syringes, with an ultimate completion date of August 13, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply framework. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,018.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zoladex 10.8 mg implant syringes, with an ultimate completion date of February 10, 2026. This non-set-aside delivery order was awarded on January 20, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that serves as a critical...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F22CGDelivery Order
The Defense Logistics Agency issued a $1,009.30 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for ZOLADEX 10.8 MG implant syringes, with an ultimate completion date of March 3, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside used.
Generated 5/10/26, 9:54 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 2/8/26 |